• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Solera Health Appoints Ian Gordon as New President & Chief Operating Officer

by Jasmine Pennic 12/14/2018 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Solera Health Appoints Ian Gordon as New President & Chief Operating Officer

Solera Health, announced this week that Ian Gordon has joined the company’s executive team as President and Chief Operating Officer. In his role, Gordon will oversee the continued development of Solera’s technology platform and drive operational excellence as Solera expands its healthcare marketplace model. 

 

Ian Gordan Background/Experience

Gordon brings extensive experience in operations leadership having served as a senior vice president of health insurance operations at Regence Blue Cross Blue Shield where he was responsible for providing leadership and strategic direction for company operations and customer experience, including efforts to improve service quality while achieving new levels of efficiency and effectiveness. Gordon joined Regence in 2014 from McKesson Health Solutions, where he served as senior vice president and general manager. Previously, he served as chief operations officer at BlueCross and BlueShield of North Carolina, president, and CEO of Topaz Shared Services and president at Meritain Health.

Solera Evolution

Solera offers an extended care marketplace that connects patients, payers, and physicians with a preferred network of providers paid for outcomes through Solera’s clearinghouse function. Over the past year, Solera has evolved its technology platform to support a broader ecosystem of community and digital network partners to support the company’s strategy to match health plan members to a curated network of chronic condition prevention and management, social determinants of health and behavioral health providers. Solera’s network model has already proven its effectiveness in scaling the Diabetes Prevention Program nationwide with over 40 million lives currently under contract.

“This is a seminal time in the evolution of Solera Health’s business as the potential of the company’s unique marketplace model is now being fully recognized,” said Brenda Schmidt, CEO of Solera Health. “Ian has an exceptional track record of leading organizations and implementing transformational operational strategies. I look forward to collaborating closely with him as Solera converts a fragmented healthcare landscape into a curated ecosystem of integrated solutions for monitoring, managing and improving patient health.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Solera Health

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |